- Eison AS, Eison MS, Torrente JR et al (1990) Nefazodone: preclinical pharmacology of a new antidepressant Psychaphar-macol Bull 26:311-5.
- Barbhaiya RH, Shukla UA, Chaikin P et al (1996) Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and urne to attain steady-state plasma concentrations after dose escalation and de-escalation. Eur J Clin Pharmacol X: 101-7.
- von Moltke LL, Greenblatt DJ, Granda BW et al (1999) Nefazodone, meta-chlorophenylpiperazine, and their metabo-lites in vitro: cytochromes mediating transformation, and P450-3A4 inhibitory actions. Psychopharmacology 145: 113-22.
- Bertz RJ, Granneman GR (1997) Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.Clin Pharmacokinet 32: 210-58.
- Piscitelli SC, Burstein AH, Chaitt D et al (2000) Indinavir concentrations and St John's wort. Lancet 355: 547-8.
- Lantz MS, Buchalter E, Giambanco V (1999) St. John's wort and antidepressant drug interactions in the elderly. J Geriatr Psych Neural 12: 7-10.
- Wright DH, Lake KD, Bruhn PS, Emery RW (1999) Nefezodone and cyclosporine drug-drug interaction. J Heart Lung Transplant 18: 913-5.
- Helms-Smith KM, Curtis SL (1996) Apparent interaction between nefazodone and cyclosporine. Ann Intern Med 125: 424.
- Vella JP, Sayegh MH (1998) Interactions between cyclosporine and newer antidepressant medications. Am J Kidney Dis 31: 320-3.
- Olyaei AJ, deMattos AM, Norman DJ, Bennett WM (1998) Interaction between tacrolimus and nefazodone in a stable renal transplant recipient Pharmacotherapy 18: 1356-9.
- Campo JV (1998) Tacrolimus toxic reaction associated with the use of nefazodone: paroxetine as an alternative agent Arch Gen Psych 55: 1050-1.
- Jacobson RH, Glueck CJ (1997) Myositis and rhabdomyolysis associated with concurrent use of simvastatin and nefazodone. JAMA 277: 296-7.
- Ashton AK, Wolin RE (1996) Nefazodone-induced carbama-zepine toxicity. Am J Psychiatry 153: 733.
- Christians U, Jacobsen W, Floren L.C (1998) Metabolism and drag interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? Pharmacol Ther 80: 1-34.
- Alderman CP (1999) Possible interaction between nefazodone and pravastatin. Ann Pharmacother 33: 871.
- Salazar DE, Dockens RC, Milbrath RL et al (1995) Pharmaco-kinetic and pharmacodynamic evaluation of warfarin and nefazodone coadministration in healthy subjects. J Clin Pharmacol 35: 730-8.
- Dockens RC, Greene DS, Barbhaiya RH (1996) Assessment of pharmacokinetic and pharmacodynamic drag interactions between nefazodone and digoxin in healthy male volunteers. J Clin Pharmacol 36: 160-7.
- Taylor D, Bodani M, Hubbeling A, Murray R (1999) The effect of nefazodone on clozapine plasma concentrations. M Clin Psychopharmacol 14: 185-7.
- Dockens RC, Rapoport D, Roberts D, et al (1995) Lack of an effect of nefazodone on the pharmacokinetics and pharmaco-dynamics of theophylline during concurrent administration in patients with chronic obstructive pulmonary disease. Br J Clin Pharmacol 40: 598-601.
- Marino MR, Langenbacher KM, Hammett JL et al (1997) The effect of nefazodone on the single-dose pharmacokinetics of phenytoin in healthy male subjects. J clin Psychopharmacol 17: 27-33.
- Buur-Rassmussen B, Brosen K (1999) Cytochrome P450 and therapeutic drug monitoring with respect to clozapine. Eur Neuropsychopharmacd 9: 453-9.
- Salazar DE, Marathe PH, Fulmor IE et al (1995) Pharmacoki-netic and pharmacodynamic evaluation during coadministra-tion of nefazodone and propranolol in healthy men. J Clin Pharmacol 35: 1109-18.
- Rotzinger S, Fang J, Coutts RT, Baker GB (1998) Human CYP2D6 and metabolism of m-chlorophenylpiperazine. Biol Psychiatry 44: 1185-91.
- Retting MV, Evans WE (1992) Genetic polymorphism of drag metabolism. In: Applied Pharmacokinetics (3rd edn) (eds WE Evans, JJ Schentag, WJ Jusko) Applied Therapeutics, Vancou-ver.
- Greene DS, Barbhaiya RH (1997) Clinical pharmacokinetics of nefazodone.Clin Pharmacokinet 33: 260-75.
- Sevy S, Brown SL, Wetzler S et al (1994) Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine. Psychiatry Res 53: 219-29.
- Greenberg WM (1999) Visual field "shimmering" associated with nefazodone. J Clin Psychiatry 60: 124.
- Horton JC, Trobe JD (1999) Akinetopsia from nefazodone toxicity. Am J Ophthalmol 128: 530-0.
- Schwartz K (1997) Nefazodone and visual side effects. Am J Psychiatry 154: 1038.
- Dubin J, Spier S, Giannadrea P (1997) Nefazodone-induced mania. Am J Psychiatry 154: 578-9.
- WarnockJK (1997) Nefazodone-induced hypoglycemia in a diabetic patient with major depression. Am J Psychiatry 154: 288-9.
- Ghaemi SN, Irizarry MC (1995) Paresthesia as a side effect of the new antidepressant, nefazodone. Can J Psychiatry 40: 499500.
- Puzantian T, Shaw RJ (1996) Nefazodone and symptoms suggesting neurotoxicity: a case report J Clin Psychiatry 57: 595.
- van Laar MW (1997) Nefazodone: psychomotor and cognitive effects. Drugs 54: 186-7.
- Eberstein S, Adler LA, Angrist B (1996) Nefazodone and akathisia. Biol Psychiatry 40: 798-9.
- Brodie-Meijer CC, Diemont WL, Buijs PJ (1999) Nefazodone-induced clitoral priapism. Int Clin Psychopharmacol 14: 257-8.
- Schrader GD, Roberts-Thompson IC (1999) Adverse effect of nefazodone: hepatitis. Med J Aust 170: 452.
- Lucena MI, Andrade RJ, Gomez-Outes A et al (1999) Acute liver failure after treatment with nefazodone. Dig Dis Sci 44: 2577-9.
- Aranda-Michel J, Koehler A, Bejarano PA et al (1999) Nefazodone-induced liver failure: report of three cases. Ann Intern Med 130: 285-8.
- Pecknold JC, Langer SF (1996) Priapism: trazodone versus nefazodone J Clin Psychiatry 57: 547-8.
- Hirschfeld RM (1999) Management of sexual side effects of antidepressant therapy. J Clin Psychiatry 60 (suppl 14): 27-30.
- Segraves RT (1998) Antidepressant-induced sexual dysfunction. J Clin Psychiatry 59 (suppl 4): 48-54.
- Feiger A, Kiev A, Shrivastava RK et al (1996) Nefazodone versus sertrataline in outpatients with major depression: focus on efficacy, tolerability, and effects on sexual function and satisfaction.; Clin Psychiatry 57 (suppl 2): 53-61
- Armitage R (1999) The effects of nefazodone on sleep in depressed patients and healthy controls. Int J Psych Clin Pract 3: 73-9.
- Thase ME (1998) Depression, sleep, and antidepressants. J Clin Psychiatry 59 (suppl 4): 55-65.
- Sharpley Al, Williamson DJ, Attenburrow MEJ et al (1996) The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacolcgy 126: 50-4.
- Rush AJ, Armitage R, Gillin JC et al (1998) Comparative effects of nefazodone and fluoxetine on sleep in outpatients with major depressive disorder. Biol Psychiatry 44: 3-14.
- Saxena PR (1995) Serotonin receptors: Subtypes, functional responses, and therapeutic relevance. Pharmacol Ther 66: 33968.
- Hedges DW, Reimherr FW, Strong RE et al (1996) An open trial of nefazodone in adult patients with generalized anxiety disorder. Psychopharmacol Bull 32: 671-6.
- Hidalgo R, Hertzberg MA, Mellman T et al (1999) Nefazodone in post-traumatic stress disorder: results from six open-label trials. Int Clin Psychopharmacol 14: 61-8.
- Bystritsky A, Rosen R, Suri R, Vapnik T (1999) Pilot open-label study of nefazodone in panic disorder. Depress Anxiety 10: 137-9.
- Worthington JJ 3rd, Zucker BG, Fones CS et al (1998) Nefazodone for social phobia: a clinical case series. Depress Anxiety 8: 131-3.
- Mancini C, Van Ameringen M, Oakman JM, Farvolden P (1999) Serotonergic agents in the treatment of social phobia in children and adolescents: a case series. Depress Anxiety 10: 33-9.
- Fawcett J, Kravitz HM (1983) Anxiety syndromes and their relationship to depressive illness. J Clin Psychiatry 44: 8-11.
- Fawcett J, Marcus RN, Anton SF et al (1995) Response of anxiety and agitation symptoms during nefazodone treatment of major depression. J Clin Psychiatry 56 (suppl 6): 37-41
- Zajecka JM (1996) The effect of nefazodone on comorbid anxiety symptoms associated with depression: experience in family practice and psychiatric outpatient settings. J Clin Psychiatry 57 (suppl 2): 10-14.
- Joffe G, Appelberg B, Rimon R (1999) Adjunctive nefazodone in neuroleptic-treated schizophrenic patients with predominantly negative symptoms: an open prospective pilot study. Int Clin Psychopharmacol 14: 233-8.
- Frewer LJ, Lader M (1993) The effects of nefazodone, imipramine and placebo, alone and combined with alcohol, in normal subjects. Int J Clin Psychopharmacol & 13-20.
International Journal of Psychiatry in Clinical Practice
Volume 4, 2000 - Issue 4